Effective February 28, 2026, the board of directors of Sunho Biologics, Inc. (Stock Code: 2898) will comprise Executive Directors Zhang Feng and Jiang Xiaoling, Non-executive Director Fan Rongkui, and Independent Non-executive Directors Chan Heung Wing Anthony, Feng Lan, and Shi Luwen.

The three board committees will be Audit, Remuneration, and Nomination. Zhang Feng serves as a member of the Nomination Committee and the chairman of the Remuneration Committee, while Chan Heung Wing Anthony chairs the Audit Committee. Feng Lan is a member of the Audit Committee, chairs the Nomination Committee, and serves as a member of the Remuneration Committee. Shi Luwen serves as a member of all three committees.